Organogenesis Holdings (ORGO) Long-Term Deferred Tax: 2017-2025
Historic Long-Term Deferred Tax for Organogenesis Holdings (ORGO) over the last 7 years, with Sep 2025 value amounting to $45.6 million.
- Organogenesis Holdings' Long-Term Deferred Tax rose 27.03% to $45.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.6 million, marking a year-over-year increase of 27.03%. This contributed to the annual value of $39.5 million for FY2024, which is 40.93% up from last year.
- Latest data reveals that Organogenesis Holdings reported Long-Term Deferred Tax of $45.6 million as of Q3 2025, which was up 9.19% from $41.8 million recorded in Q2 2025.
- In the past 5 years, Organogenesis Holdings' Long-Term Deferred Tax ranged from a high of $45.6 million in Q3 2025 and a low of $18,000 during Q1 2021.
- For the 3-year period, Organogenesis Holdings' Long-Term Deferred Tax averaged around $34.8 million, with its median value being $33.7 million (2024).
- Per our database at Business Quant, Organogenesis Holdings' Long-Term Deferred Tax soared by 177,644.44% in 2021 and then dropped by 6.70% in 2023.
- Organogenesis Holdings' Long-Term Deferred Tax (Quarterly) stood at $32.0 million in 2021, then dropped by 6.19% to $30.0 million in 2022, then decreased by 6.70% to $28.0 million in 2023, then surged by 40.93% to $39.5 million in 2024, then climbed by 27.03% to $45.6 million in 2025.
- Its last three reported values are $45.6 million in Q3 2025, $41.8 million for Q2 2025, and $40.7 million during Q1 2025.